{
    "2019-10-28": [
        [
            {
                "time": "",
                "original_text": "国信医药】乐普医疗：器械增长提速，业绩符合预期（三季报点评）",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "器械",
                        "增长提速",
                        "业绩",
                        "三季报"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "外资持仓最新动向：QFII新进36股，陆股通增持银行、地产",
                "features": {
                    "keywords": [
                        "外资",
                        "QFII",
                        "陆股通",
                        "增持",
                        "银行",
                        "地产"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "银行",
                        "地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华泰医药代雯团队】乐普医疗（300003.SZ）三季报点评：稳健依旧，昂首前行",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "华泰医药",
                        "三季报",
                        "稳健",
                        "昂首前行"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗2019年三季报点评:内生利润保持超30%较高增长,耗材集采不必过于悲观",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "三季报",
                        "内生利润",
                        "30%增长",
                        "耗材集采",
                        "悲观"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}